Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Space Compass and SWISSto12 have executed a procurement contract for the first GEO optical data relay satellite. This agreement represents a milestone toward the realisation of Space Compass’s optical ...

Investing.com - Stifel reiterated a Buy rating and $12.00 price target on Compass Therapeutics (NASDAQ:CMPX) shares, well above the current stock price of $5.10. The biotech company has delivered a ...

NASHVILLE, Tenn., March 19, 2026 (GLOBE NEWSWIRE) -- The Costigan Group at Compass rolls out a structured pre-acquisition screening framework for short-term rental investors, giving buyers a ...

Space Compass Corporation ("Space Compass") and SWISSto12 SA ("SWISSto12") announced today that they have executed a procurement contract for the first GEO optical ...